Gene · 1075
Papers2,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatic analysis reveals lysosome-related biomarkers and molecular subtypes in preeclampsia: novel insights into the pathogenesis of preeclampsia. | Front Genet | 2023 | 37576559 | PubTator, text mining | PubMed |
| The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO. | Orphanet J Rare Dis | 2023 | 37573351 | PubTator, text mining | PubMed |
| Integrated Analysis Identifies DPP7 as a Prognostic Biomarker in Colorectal Cancer. | Cancers (Basel) | 2023 | 37568770 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Transplantation of human induced pluripotent stem cell derived keratinocytes accelerates deep second-degree burn wound healing. | World J Stem Cells | 2023 | 37545758 | PubTator, text mining | PubMed |
| A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia. | Nat Commun | 2023 | 37542039 | PubTator, text mining | PubMed |
| BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis. | Inflamm Res | 2023 | 37542002 | PubTator, text mining | PubMed |
| The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species. | Front Pharmacol | 2023 | 37538173 | PubTator, text mining | PubMed |
| Comparative proteomics of proliferative diabetic retinopathy in people with Type 2 diabetes highlights the role of inflammation, visual transduction, and extracellular matrix pathways. | Indian J Ophthalmol | 2023 | 37530283 | PubTator, text mining | PubMed |
| A transcriptome-based single-cell biological age model and resource for tissue-specific aging measures. | Genome Res | 2023 | 37524436 | PubTator, text mining | PubMed |
| Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy. | Front Immunol | 2023 | 37520562 | PubTator, text mining | PubMed |
| The Potential Role of Timosaponin-AIII in Cancer Prevention and Treatment. | Molecules | 2023 | 37513375 | PubTator, text mining | PubMed |
| Origin and Early Diversification of the Papain Family of Cysteine Peptidases. | Int J Mol Sci | 2023 | 37511529 | PubTator, text mining | PubMed |
| Fetal Pulmonary Venous Return: From Basic Research to the Clinical Value of Doppler Assessment. | Pediatr Cardiol | 2023 | 37505268 | PubTator, text mining | PubMed |
| Cathepsin-C mutation in an individual with phenotypic features of Haim-Munk syndrome: a case report. | Clin Exp Dermatol | 2023 | 37493199 | PubTator, text mining | PubMed |
| The value of left atrial longitudinal strain in evaluating left atrial appendage spontaneous echo contrast in non-valvular atrial fibrillation. | Front Cardiovasc Med | 2023 | 37485259 | PubTator, text mining | PubMed |
| Lysosomes, curcumin, and anti-tumor effects: how are they linked? | Front Pharmacol | 2023 | 37484013 | PubTator, text mining | PubMed |
| Lipid nanoparticle delivery of siRNA targeting Cyp2e1 gene attenuates subacute alcoholic liver injury in mice. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 37476942 | PubTator, text mining | PubMed |
| Characterizing the urinary proteome of prematurity-associated lung disease in school-aged children. | Respir Res | 2023 | 37474963 | PubTator, text mining | PubMed |
| A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf. | ERJ Open Res | 2023 | 37465817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/papers?page=15